Your browser doesn't support javascript.
loading
Blood chemokine levels are markers of disease activity but not predictors of remission in early rheumatoid arthritis.
Aldridge, Jonathan; Lundell, Anna-Carin; Andersson, Kerstin; Mark, Linda; Lund Hetland, Merete; Østergaard, Mikkel; Uhlig, Till; Schrumpf Heiberg, Marte; Haavardsholm, Espen A; Nurmohamed, Michael; Lampa, Jon; Nordström, Dan; Hørslev-Petersen, Kim; Gudbjornsson, Bjorn; Gröndal, Gerdur; van Vollenhoven, Ronald; Rudin, Anna.
Affiliation
  • Aldridge J; Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden. jonathan.aldridge@gu.se.
  • Lundell AC; Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden.
  • Andersson K; Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden.
  • Mark L; Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden.
  • Lund Hetland M; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
  • Østergaard M; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
  • Uhlig T; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.
  • Schrumpf Heiberg M; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.
  • Haavardsholm EA; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, and Institute of Clinical Medicine, University of Oslo, Norway.
  • Nurmohamed M; Amsterdam Rheumatology and Immunology Center, Reade, and Department of Rheumatology and Amsterdam Rheumatology Center, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
  • Lampa J; Department of Medicine, Rheumatology Unit, Center for Molecular Medicine (CMM), Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
  • Nordström D; Department of Medicine and Rheumatology, Helsinki University and University Hospital, Helsinki, Finland.
  • Hørslev-Petersen K; Danish Hospital for Rheumatic Diseases, University Hospital of Southern Denmark, Sønderborg, and Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.
  • Gudbjornsson B; Centre for Rheumatology Research, Landspitali University Hospital, Reykjavik, and Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
  • Gröndal G; Centre for Rheumatology Research, Landspitali University Hospital, Reykjavik, and Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
  • van Vollenhoven R; Department of Rheumatology and Amsterdam Rheumatology Center, Amsterdam University Medical Centres, Amsterdam, and Department of Medicine, Rheumatology Unit, Center for Molecular Medicine (CMM), Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
  • Rudin A; Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, and Rheumatology clinic, Sahlgrenska University Hospital, Gothenburg, Sweden.
Clin Exp Rheumatol ; 40(7): 1393-1402, 2022 Jul.
Article in En | MEDLINE | ID: mdl-34796837
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Antirheumatic Agents Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Exp Rheumatol Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Antirheumatic Agents Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Exp Rheumatol Year: 2022 Document type: Article Affiliation country: Country of publication: